Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Subscribe To Our Newsletter
A BREAKDOWN OF THE ROUND 2 GRANTS
GFO Issue 7

A BREAKDOWN OF THE ROUND 2 GRANTS

Author:

Bernard Rivers

Article Type:
Analysis

Article Number: 6

ABSTRACT A breakdown of the Round 2 grants by year, region, disease, implementing entity, form of expenditure, and more.

The following data are obtained primarily from a Secretariat paper to the Board entitled “Report of the Secretariat and the Technical Review Panel on Round 2 Proposals” (Revision 1) and a Secretariat slide show entitled “Summary of Key Findings from Round Two”, both dated January 2003.

Regional split of proposals received in Round 2:

(in dollars to be spent over 5 years; 100% = $5.1 b.)

 Africa:  . . 58% S.E. Asia: . 12% Americas:. . 13% Eastern Med.  6% Europe:. . .  5% West Pacific  5% Global:. . .  1%

Disease component split of proposals received in Round 2:

(in dollars to be spent over 5 years; 100% = $5.1 b.)

 HIV/AIDS: . 59% Malaria:. . 23% TB: . . . . 11% HIV/TB: . .  7% Integrated: 1%

Source of application of proposals received in Round 2:

(in dollars to be spent over 5 years; 100% = $5.1 b.)

 CCM:  . . . . 89% Regional org:  6% NGO:  . . . .  3% Sub CCM:  . .  2% Regional CCM: 1% Other:  . . . 1%

Outcome of the review process:

(in dollars to be spent over 5 years; 100% = $5.1 b.)

 Approved (Category 1):  4% Approved (Category 2): 35% Rejected (Category 3): 55% Rejected (Category 4):  6%

Definitions:

  • Approved (Category 1): Approved proposal requiring no or minor modifications, which should easily be answered within 6 weeks and given the final approval by the TRP Chair and Co-Chair.
  • Approved (Category 2): Approved proposal provided clarifications are met within a limited timeframe (6 weeks for the applicant to respond, at most 6 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer, secondary reviewer as well as TRP Chair and/or Co-Chair need to give final approval.
  • Rejected (Category 3): Not recommended in its present form but strongly encouraged to re-submit.
  • Rejected (Category 4): Not recommended for funding.

Cost of approved proposals:

 Year 1:      $430 m. Years 1-2:   $866 m. Years 1-3: $1,276 m. Years 1-4: $1,651 m. Years 1-5: $2,051 m.

Regional split of proposals approved in Round 2:

(in dollars to be spent over 2 years; 100% = $866 m.)

 Africa:  . . 61% S.E. Asia: .  9% Americas:  .  9% Eastern Med.  8% Europe:  . .  9% West Pacific  4%

Disease component split of proposals approved in Round 2:

(in dollars to be spent over 2 years; 100% = $866 m.)

 HIV/AIDS: . 57% Malaria:  . 28% TB: . . . . 14% HIV/TB: . .  1% Integrated: 1%

Expenditure split of proposals approved in Round 2:

(in dollars to be spent over 5 years; 100% = $2,051 m.)

 Drugs: . . . . . . . .  30% Commodities & products: 26% Training & planning: .  11% Human resources: . . .   9% Infrastructure & equip.: 9% Administrative costs:    6% Monitoring & eval'n.:    5% Other: . . . . . . . .   4%

Distribution split among implementing partners for proposals approved in Round 2:

(in dollars to be spent over 5 years; 100% = $2,051 m.)

 Government: . . . . . . . . . . . 54% NGO:  . . . . . . . . . . . . . . 23% Faith-based orgs: . . . . . . . . 18% Private sector: . . . . . . . . .  5% Academic/educ. orgs:  . . . . . .  4% People living with HIV/TB/malaria: 3% Community-based orgs:   . . . . .  3% Other:  . . . . . . . . . . . . .  4%

Antiretroviral recipients in developing countries:

 Currently: - Sub-Saharan Africa: . . .  50,000 - All other dev. Countries: 250,000 - Total:  . . . . . . . . . 300,000
 Supported by Round 1 grants, by end of 5 years: - Sub-Saharan Africa: . . .  80,000 - All other dev. Countries: 140,000 - Total:  . . . . . . . . . 220,000
 Supported by Round 2 grants, by end of 5 years: - Sub-Saharan Africa: . . . 190,000 - All other dev. Countries:  80,000 - Total:  . . . . . . . . . 270,000
 Total: - Sub-Saharan Africa: . . . 320,000 - All other dev. Countries: 470,000 - Total:  . . . . . . . . . 790,000

Antiretroviral recipients from Round 2 grants by end of 5 years (or earlier, in some cases):

 Armenia . . . . . .      30 Benin . . . . . . .   2,000 Botswana  . . . . .  20,000 Bulgaria  . . . . .     200 Burkina Faso  . . .   3,600 Cambodia  . . . . .   3,000 Central African Rep.  5,000 Cote d'Ivoire . . .  27,000 Cuba  . . . . . . .   1,500 Dominican Republic    6,000 Ecuador . . . . . .   1,659 El Salvador . . . .     447 Estonia . . . . . .     500 Ethiopia  . . . . .  12,000 Georgia . . . . . .     130 Guinea  . . . . . .   4,358 India . . . . . . .   6,000 Iran  . . . . . . .     100 Jordan  . . . . . .      30 Kazakhstan  . . . .     450 Kenya . . . . . . .  20,387 Kyrgyzstan  . . . .     100 Lesotho . . . . . .  25,000 Liberia . . . . . .   1,500 Mongolia  . . . . .       5 Mozambique  . . . .  31,000 Namibia . . . . . .  26,735 Nepal . . . . . . .   3,000 Nicaragua . . . . .     390 Peru  . . . . . . .   9,000 Swaziland . . . . .   6,750 Thailand  . . . . .  48,385 Togo  . . . . . . .   1,500
 Total:  . . . . . . 267,756

Leave a reply

  • Anonymous comments (0)
  • Facebook Comments

Your email address will not be published.

Aidspan

Categories*

Loading
Aidspan

Categories*

Loading